FIRST AMENDMENT TO THE RESEARCH AGREEMENTThe Research Agreement • October 15th, 2004 • Trimeris Inc • Biological products, (no disgnostic substances)
This AMENDMENT TO THE RESEARCH AGREEMENT (“Amendment”) is executed to be effective this 13th day of November 2003, by and between Trimeris, Inc. (“Trimeris”), and F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (collectively, “Roche”).
RECITALSThe Research Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
AMENDMENT TO THE RESEARCH AGREEMENT BETWEEN IASO BIOMED US INC., AND THE RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTREThe Research Agreement • March 24th, 2017 • IASO BioMed, Inc. • Pharmaceutical preparations • Quebec
This Amendment Number One (this “Amendment”), effective January 8, 2017, to the Research Agreement between IASO Biomed, Inc., and the Research institute of the McGill University Health Centre, effective January 8, 2016,
AMENDMENT TO THE RESEARCH AGREEMENT BETWEEN IASO BIOMED US INC., AND THE RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTREThe Research Agreement • April 24th, 2019 • IASO BioMed, Inc. • Pharmaceutical preparations • Quebec
This Amendment Number Two (this “Amendment”) to the Research Agreement between IASO Biomed, Inc. and the Research Institute of the McGill University Health Centre, effective January 8, 2016
SECOND AMENDMENT TO THE RESEARCH AGREEMENTThe Research Agreement • February 21st, 2006 • Trimeris Inc • Biological products, (no disgnostic substances)
This SECOND AMENDMENT TO THE RESEARCH AGREEMENT ("Second Amendment") is executed to be effective this 31st day of December 2005 ("Second Amendment Effective Date"), by and between Trimeris, Inc. ("Trimeris"), and F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (collectively, "Roche") (Roche and Trimeris together referred to as the "Parties").
